Investors
Segment Data and Regional Results
Quarterly Statement Q3 2026
Segment Data
Segment data — Chemicals
Q3 | January – September | |||||
| Million € | 2026 | 2025 | +/- | 2026 | 2025 | +/- |
| Sales to third parties | 3,394 | 2,526 | 34.4% | 9,651 | 7,805 | 23.7% |
of which Petrochemicals | 2,717 | 1,884 | 44.2% | 7,635 | 5,825 | 31.1% |
Intermediates | 677 | 642 | 5.4% | 2,015 | 1,979 | 1.8% |
| EBITDA before special items | 409 | 262 | 56.1% | 1,019 | 807 | 26.3% |
| Special items in EBITDA | -19 | -20 | 4.0% | -50 | -59 | 15.9% |
| EBITDA | 390 | 242 | 61.1% | 970 | 748 | 29.7% |
| EBITDA margin before special items (%) | 12.1 | 10.4 | . | 10.6 | 10.3 | . |
| Depreciation and amortizationa | 337 | 250 | 34.7% | 931 | 688 | 35.4% |
| EBIT before special items | 91 | 30 | 201.2% | 106 | 145 | -26.8% |
| Special items in EBIT | -38 | -38 | 1.7% | -68 | -85 | 20.2% |
| Income from operations (EBIT) | 53 | -8 | . | 38 | 60 | -36.2% |
| Investments including acquisitionsb | 193 | 469 | -58.9% | 921 | 1,441 | -36.1% |
| Segment cash flow | 318 | -38 | . | -530 | -605 | 12.3% |
| Assets (September 30) | 15,882 | 14,042 | 13.1% | 15,882 | 14,042 | 13.1% |
| Research and development expenses | 19 | 21 | -7.5% | 60 | 62 | -3.6% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
Segment data — Materials
Q3 | January–September | |||||
| Million € | 2026 | 2025 | +/- | 2026 | 2025 | +/- |
| Sales to third parties | 3,735 | 3,153 | 18,5% | 10,763 | 9,842 | 9,4% |
of which Performance Materials | 1,728 | 1,564 | 10,5% | 5,039 | 4,977 | 1,2% |
Monomers | 2,007 | 1,588 | 26,3% | 5,724 | 4,865 | 17,7% |
| EBITDA before special items | 551 | 408 | 35.0% | 1,854 | 1,286 | 44,2% |
| Special items in EBITDA | -21 | -1 | . | -52 | -34 | -54,7% |
| EBITDA | 530 | 407 | 30,3% | 1,802 | 1,252 | 43,9% |
| EBITDA margin before special items (%) | 14.8 | 13.0 | . | 17.2 | 13.1 | . |
| Depreciation and amortizationa | 531 | 208 | 155,5% | 906 | 643 | 40,8% |
| EBIT before special items | 340 | 211 | 60,9% | 1,268 | 656 | 93,4% |
| Special items in EBIT | -340 | -12 | . | -372 | -47 | -696,6% |
| Income from operations (EBIT) | 0 | 199 | . | 896 | 609 | 47,2% |
| Investments including acquisitionsb | 162 | 310 | -47,7% | 464 | 646 | -28,1% |
| Segment cash flow | 365 | 338 | 8.0% | 395 | 638 | -38,1% |
| Assets (September 30) | 10,221 | 9,475 | 7,9% | 10,221 | 9,475 | 7,9% |
| Research and development expenses | 42 | 46 | -7,9% | 128 | 137 | -6,4% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to intangible assets and property, plant and equipment
Segment data — Industrial Solutions
Q3 | January – September | |||||
| Million € | 2026 | 2025 | +/- | 2026 | 2025 | +/- |
| Sales to third parties | 2,387 | 2,134 | 11.8% | 6,807 | 6,563 | 3.7% |
of which Dispersions & Resins | 1,367 | 1,194 | 14.5% | 3,939 | 3,743 | 5.2% |
Performance Chemicals | 1,020 | 940 | 8.5% | 2,868 | 2,820 | 1.7% |
| EBITDA before special items | 434 | 291 | 49.2% | 1,229 | 958 | 28.2% |
| Special items in EBITDA | -10 | -11 | 3.8% | -65 | -25 | -159.6% |
| EBITDA | 424 | 280 | 51.3% | 1,164 | 933 | 24.7% |
| EBITDA margin before special items (%) | 18.2 | 13.6 | . | 18.1 | 14.6 | . |
| Depreciation and amortizationa | 97 | 109 | -11.4% | 340 | 322 | 5.5% |
| EBIT before special items | 338 | 192 | 76.3% | 936 | 647 | 44.7% |
| Special items in EBIT | -11 | -21 | 45.2% | -112 | -35 | -216.4% |
| Income from operations (EBIT) | 327 | 171 | 91.1% | 824 | 611 | 34.8% |
| Investments including acquisitionsb | 83 | 95 | -12.8% | 227 | 240 | -5.7% |
| Segment cash flow | 276 | 353 | -21.6% | 322 | 718 | -55.2% |
| Assets (September 30) | 7,324 | 6,759 | 8.4% | 7,324 | 6,759 | 8.4% |
| Research and development expenses | 45 | 45 | 0.4% | 131 | 139 | -5.8% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to intangible assets and property, plant and equipment
Segment data — Nutrition & Care
Q3 | January – September | |||||
| Million € | 2026 | 2025 | +/- | 2026 | 2025 | +/- |
| Sales to third parties | 1,755 | 1,637 | 7.2% | 5,133 | 4,974 | 3.2% |
of which Care Chemicals | 1,262 | 1,187 | 6.3% | 3,718 | 3,655 | 1.7% |
Nutrition & Health | 492 | 450 | 9.5% | 1,416 | 1,319 | 7.3% |
| EBITDA before special items | 237 | 134 | 76.4% | 632 | 559 | 13.0% |
| Special items in EBITDA | -94 | 50 | . | -111 | 39 | . |
| EBITDA | 143 | 184 | -22.4% | 522 | 598 | -12.8% |
| EBITDA margin before special items (%) | 13.5 | 8.2 | . | 12.3 | 11.2 | . |
| Depreciation and amortizationa | 139 | 158 | -12.1% | 421 | 420 | 0.2% |
| EBIT before special items | 97 | 4 | . | 212 | 176 | 20.0% |
| Special items in EBIT | -93 | 21 | . | -111 | 2 | . |
| Income from operations (EBIT) | 4 | 25 | -86.2% | 101 | 178 | -43.5% |
| Investments including acquisitionsb | 62 | 170 | -63.8% | 231 | 478 | -51.6% |
| Segment cash flow | -21 | -34 | 38.1% | -80 | -164 | 51.4% |
| Assets (September 30) | 8,134 | 7,774 | 4.6% | 8,134 | 7,774 | 4.6% |
| Research and development expenses | 27 | 33 | -17.0% | 86 | 102 | -15.2% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
Segment data — Surface Technologiesa
Q3 | January – September | |||||
| Million € | 2026 | 2025 | +/- | 2026 | 2025 | +/- |
| Sales to third parties | 2,529 | 2,302 | 9.9% | 7,560 | 6,846 | 10.4% |
of which Battery Materials | 164 | 151 | 8.8% | 474 | 442 | 7.2% |
Metivoa | 2,364 | 2,031 | 16.4% | 7,087 | 6,057 | 17.0% |
Coatingsb | – | 120 | . | – | 347 | . |
| EBITDA before special items | 201 | 328 | -38.9% | 591 | 670 | -11.8% |
| Special items in EBITDA | -8 | -23 | 65.5% | -24 | -68 | 63.8% |
| EBITDA | 193 | 305 | -36.8% | 567 | 603 | -5.9% |
| EBITDA margin before special items (%) | 7.9 | 14.3 | . | 7.8 | 9.8 | . |
| Depreciation and amortizationc | 49 | 54 | -9.0% | 150 | 167 | -9.9% |
| EBIT before special items | 153 | 276 | -44.3% | 447 | 508 | -12.1% |
| Special items in EBIT | -10 | -24 | 60.5% | -30 | -72 | 58.2% |
| Income from operations (EBIT) | 144 | 252 | -42.8% | 416 | 436 | -4.4% |
| Investments including acquisitionsd | 32 | 35 | -8.1% | 76 | 86 | -10.9% |
| Segment cash flow | 284 | 274 | 3.7% | 404 | 336 | 20.4% |
| Assets (September 30) | 6,208 | 6,108 | 1.6% | 6,208 | 6,108 | 1.6% |
| Research and development expenses | 33 | 36 | -6.4% | 102 | 118 | -13.5% |
a Previously Environmental Catalyst and Metal Solutions (ECMS)
b The figures of the Coatings division refer exclusively to the decorative paints business unit.
c Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
d Additions to property, plant and equipment and intangible assets
Segment data — Agricultural Solutions
Q3 | January – September | |||||
| Million € | 2026 | 2025 | +/- | 2026 | 2025 | +/- |
| Sales to third parties | 1,404 | 1,748 | -19.7% | 6,718 | 7,150 | -6.0% |
of which Fungicides | 470 | 604 | -22.2% | 2,068 | 2,124 | -2.6% |
Herbicides | 316 | 461 | -31.3% | 2,023 | 2,230 | -9.3% |
Insecticides | 237 | 266 | -11.0% | 752 | 810 | -7.2% |
Seed Treatment | 108 | 154 | -29.7% | 380 | 411 | -7.7% |
Seeds & Traits | 272 | 263 | 3.3% | 1,496 | 1,575 | -5.0% |
| EBITDA before special items | -48 | 80 | . | 1,501 | 1,700 | -11.7% |
| Special items in EBITDA | -30 | -36 | 15.6% | -87 | -114 | 23.8% |
| EBITDA | -78 | 44 | . | 1,414 | 1,586 | -10.8% |
| EBITDA margin before special items (%) | -3.4 | 4.5 | . | 22.3 | 23.8 | . |
| Depreciation and amortizationa | 128 | 132 | -3.1% | 402 | 435 | -7.5% |
| EBIT before special items | -179 | -53 | -240.5% | 1,098 | 1,267 | -13.3% |
| Special items in EBIT | -27 | -36 | 23.7% | -86 | -116 | 25.8% |
| Income from operations (EBIT) | -206 | -88 | -133.6% | 1,012 | 1,151 | -12.1% |
| Investments including acquisitionsb | 64 | 76 | -15.9% | 321 | 217 | 47.6% |
| Segment cash flow | 294 | 465 | -36.9% | 14 | 299 | -95.2% |
| Assets (September 30) | 15,928 | 15,175 | 5.0% | 15,928 | 15,175 | 5.0% |
| Research and development expenses | 218 | 249 | -12.4% | 695 | 701 | -0.9% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
Financial data — Other
Q3 | January – September | |||||
| Million € | 2026 | 2025 | +/- | 2026 | 2025 | +/- |
| Sales to third parties | 1,156 | 828 | 39.7% | 2,954 | 2,445 | 20.8% |
| EBITDA before special items | -140 | -73 | -92.5% | -379 | -460 | 17.7% |
of which costs for cross-divisional corporate research | -43 | -50 | 13.9% | -132 | -146 | 9.6% |
costs of corporate headquarters | -54 | -58 | 5.3% | -178 | -177 | -0.5% |
other businesses | 107 | 98 | 8.9% | 221 | 188 | 17.4% |
miscellaneous income and expenses | -150 | -64 | -135.6% | -290 | -326 | 10.9% |
| Special items in EBITDA | -254 | -182 | -39.9% | -701 | -660 | -6.2% |
| EBITDA | -395 | -255 | -55.0% | -1,080 | -1,120 | 3.6% |
| Depreciation and amortizationa | 24 | 64 | -62.8% | 107 | 138 | -22.4% |
| EBIT before special items | -158 | -127 | -24.6% | -472 | -588 | 19.8% |
| Special items in EBIT | -260 | -192 | -35.7% | -715 | -670 | -6.7% |
| Income from operations (EBIT) | -419 | -319 | -31.2% | -1,187 | -1,259 | 5.7% |
| Investments including acquisitionsb | 22 | 45 | -52.3% | 71 | 110 | -34.9% |
| Assets (September 30)c | 16,247 | 17,107 | -5.0% | 16,247 | 17,107 | -5.0% |
| Research and development expenses | 49 | 60 | -18.7% | 141 | 189 | -25.2% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
c Includes assets of businesses recognized under Other and reconciliation to assets of the BASF Group
Regions
| Million € | Sales | Sales | ||||
| Q3 | 2026 | 2025 | +/- | 2026 | 2025 | +/- |
| Europe | 6,616 | 5,901 | 12.1% | 6,095 | 5,452 | 11.8% |
of which Germany | 2,891 | 2,460 | 17.5% | 1,639 | 1,376 | 19.2% |
| North America | 3,913 | 3,257 | 20.1% | 3,837 | 3,147 | 21.9% |
| Asia Pacific | 4,594 | 3,716 | 23.6% | 4,825 | 3,874 | 24.5% |
of which Greater China | 2,765 | 2,068 | 33.7% | 2,878 | 2,092 | 37.6% |
| South America, Africa, Middle East | 1,237 | 1,454 | -14.9% | 1,603 | 1,855 | -13.6% |
| BASF Group | 16,360 | 14,328 | 14.2% | 16,360 | 14,328 | 14.2% |
| Million € | Sales | Sales | ||||
| January–September | 2026 | 2025 | +/- | 2026 | 2025 | +/- |
| Europe | 20,741 | 19,133 | 8.4% | 19,607 | 18,089 | 8.4% |
of which Germany | 8,480 | 7,771 | 9.1% | 4,893 | 4,543 | 7.7% |
| North America | 12,764 | 12,107 | 5.4% | 12,369 | 11,710 | 5.6% |
| Asia Pacific | 13,220 | 11,209 | 17.9% | 13,634 | 11,478 | 18.8% |
of which Greater China | 8,104 | 6,257 | 29.5% | 8,135 | 6,245 | 30.3% |
| South America, Africa, Middle East | 2,861 | 3,176 | -9.9% | 3,975 | 4,347 | -8.6% |
| BASF Group | 49,586 | 45,625 | 8.7% | 49,586 | 45,625 | 8.7% |